These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 7597186)

  • 1. [Incidence of rubella antibodies and the results of vaccination against rubella in young women].
    Kopeć J; Zgórniak-Nowosielska I
    Przegl Epidemiol; 1994; 48(4):475-9. PubMed ID: 7597186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Improvement of rubella vaccination. Seroconversion after serial rubella vaccination with the jet injector].
    Weber HG; Willers H
    Fortschr Med; 1982 Jun; 100(24):1161-3. PubMed ID: 7106679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rubella immunization of teenage girls in Iceland and follow-up after a severe rubella epidemic.
    Rafnar B
    Bull World Health Organ; 1982; 60(1):141-6. PubMed ID: 6979417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study of young women vaccinated against rubella virus for 10 years in Taiwan.
    Lin DB; Kao CL; Lee CY
    Southeast Asian J Trop Med Public Health; 1996 Dec; 27(4):707-14. PubMed ID: 9253871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prevalence of anti-rubella antibodies in women of childbearing age in Poland.
    Wysokiñska T; Janaszek W; Bucholc B; Gorska P; Gniadek G; Slusarczyk J; Rawicz M
    Vaccine; 2004 May; 22(15-16):1899-902. PubMed ID: 15121301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of HI antibody titer against rubella virus to determine the effect of mass vaccination in Tehran.
    Soleimanjahi H; Bamdad T; Fotouhi F; Roustai MH; Faghihzadeh S
    J Clin Virol; 2005 Oct; 34(2):153-4. PubMed ID: 16076562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccination of seronegative high-risk populations with attenuated rubella vaccine.
    Lehtinen MO; Hakkarainen K; Leinikki PO; Lehtinen TK; Mattila LM; Helle EP
    Ann Clin Res; 1982 Dec; 14(5-6):213-9. PubMed ID: 7171230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Studies on rubella vaccination in adult females. I: Clinical and laboratory studies on clinical reactions].
    Nakazono N
    Hokkaido Igaku Zasshi; 1984 Mar; 59(2):180-91. PubMed ID: 6745839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Susceptibility to rubella and borderline immunity.
    Fogel A; Barnea B; Gerichter CB
    Isr J Med Sci; 1983 Oct; 19(10):934-5. PubMed ID: 6363349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparative studies of the immunogenic and reactogenic properties of various vaccines against rubella. I. Seroconversion and post-vaccination reactions in girls immunized against rubella with Almevax vaccine].
    Kańtoch M; Rudnicka H; Imbs D
    Przegl Epidemiol; 1985; 39(3-4):301-8. PubMed ID: 3832164
    [No Abstract]   [Full Text] [Related]  

  • 11. [Rubella vaccination during puerperium? Effect of rubella vaccination during puerperium on the titer of HAH].
    Dennin RH; Bader C; Husstedt W
    Fortschr Med; 1978 Jul; 96(28):1407-10. PubMed ID: 669534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Rubella immunization with HPV77DE5 and RA 27/3 vaccines of 11 to 16-year-old girls: studies of antibody formation and antibody resistance after 4 and 8 years].
    Gitmans U; Enders G; Glück H; Harm B; Lindemann L
    Immun Infekt; 1983 May; 11(3):79-90. PubMed ID: 6676174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A rubella vaccination program for women entering the U.S. Army.
    Vaeth SJ
    Public Health Rep; 1979; 94(6):564-7. PubMed ID: 515343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparative studies of immunogenicity and reactogenicity of various rubella vaccines. II. Seroconversion and post-vaccination reactions in girls immunized against rubella with Rudivax and Cendevax vaccines].
    Imbs D; Kańtoch M; Rudnicka H; Niedźwiedzka-Adamaszek E; Pychyńska A; Zegadło W; Stempień R; Słowińska I; Kretkowska A
    Przegl Epidemiol; 1987; 41(2):141-8. PubMed ID: 3423282
    [No Abstract]   [Full Text] [Related]  

  • 15. [Rubella vaccination: antibody persistence for 14-17 years and immune status of women without and with a history of vaccination].
    Enders G; Nickerl U
    Immun Infekt; 1988 Apr; 16(2):58-64. PubMed ID: 3391631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immune response of rubella vaccine in the populations with different age groups].
    Xiong XW; Diao LD; Yan XL
    Zhonghua Liu Xing Bing Xue Za Zhi; 1997 Aug; 18(4):227-9. PubMed ID: 9812525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Post partum rubella vaccination and anti-D prevention].
    Pavelka R; Salzer H; Reinold E
    Zentralbl Gynakol; 1978; 100(16):1025-9. PubMed ID: 103339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of vaccination with measles-mumps-rubella vaccine at 9, 12, and 15 months of age.
    Redd SC; King GE; Heath JL; Forghani B; Bellini WJ; Markowitz LE
    J Infect Dis; 2004 May; 189 Suppl 1():S116-22. PubMed ID: 15106100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective evaluation of pregnant women vaccinated against rubella in southern Brazil.
    Minussi L; Mohrdieck R; Bercini M; Ranieri T; Sanseverino MT; Momino W; Callegari-Jacques SM; Schuler-Faccini L
    Reprod Toxicol; 2008 Jan; 25(1):120-3. PubMed ID: 17977696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Seroepidemiology of rubella in Rome (1972-1978)].
    Volpi A; Andreoni M; Resta S; Rocchi G
    Boll Ist Sieroter Milan; 1980 Jan; 58(6):453-6. PubMed ID: 7447994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.